Higher sleep drug dose may pose risk for seniors with kidney issues
NCT ID NCT07381101
Summary
This study looked at whether starting a higher dose of the sleep and depression medication trazodone is riskier than a lower dose for older adults with reduced kidney function. Researchers analyzed health records of over 31,000 people aged 66 and older in Ontario. They compared the chance of being hospitalized, visiting the emergency room, or dying within 30 days for those on higher versus lower doses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLDER ADULTS (65 YEARS AND OLDER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
London Health Sciences Centre Research Institute
London, Ontario, Canada
Conditions
Explore the condition pages connected to this study.